Meetings of Interest
Health Evidence Review Commission (HERC) Listening Session
The Health Evidence Review Commission (HERC) staff will hold a listening session for ideas and concerns related to coverage of health services on the Prioritized List on December 12, 2023, 9:00-10:30 am.
Our priority for this meeting is to hear from Oregon Health Plan (OHP) members, their caregivers and providers.
To suggest a topic for discussion, please register by Noon Pacific time on November 27, 2023 at: https://www.surveymonkey.com/r/Dec23ListeningSession
Staff may contact you to discuss your suggested topic
To attend as a “listen-only” participant, please self-register for the webinar at: https://www.zoomgov.com/webinar/register/WN_etdnWqxiQvSTrXtXqTLCow
Please mark your calendars
Staff will be available to hear your concerns or suggested topics for HERC consideration and answer questions. HERC members will not be present, and no decisions or policy changes will be approved at this time.
Questions? Please email HERC.Info@oha.oregon.gov
Tuesday, Dec 12, 2023
9:00 am to 10:30 am
About the PDAB
Senate Bill 844 created the Prescription Drug Affordability Board (PDAB) to evaluate the cost of prescription drugs and determine whether they present an affordability challenge for consumers and health systems in Oregon. PDAB’s review will inform rulemaking criteria for evaluating drugs, including health inequities in diverse communities, the number of Oregon residents prescribed the drug, the price of the drug in Oregon, and other criteria. The board has studied the prescription drug distribution and payment system in Oregon and the generic drug market and provided recommendations to the Legislature. The Oregon Legislature acted on the board recommendations by passing Senate Bill 192 in June 2023. The board statutory authority is ORS 646A.693-697.
Wednesday, Dec 13, 2023